环丝氨酸医保能否报销？

(cycloserine) is a second-line anti-tuberculosis drug. It is a broad-spectrum antibacterial drug and has weak antibacterial effects against many Gram-positive and -negative bacteria. It has an inhibitory effect on Mycobacterium tuberculosis, and its anti-Mycobacterium tuberculosis effect is far weaker than that of isoniazid and streptomycin. Its antibacterial mechanism is to interfere with the synthesis of bacterial cell walls. Today we will learn in detail whether cycloserine can be reimbursed by medical insurance?

The domestically produced version of cycloserine is a domestically produced version. Cycloserine was launched in my country in the 1970s. In 2013, the cycloserine capsule developed by Zhejiang Hisun Pharmaceutical was approved by the CFDA for production and marketing, with the trade name "Selaixing". But cycloserine is not included in medical insurance. Cycloserine, produced by Macleods Pharmaceuticals in India, comes in a box of 250mg*60 capsules and is sold in Indian pharmacies for about $500. Patients in need can go abroad to purchase drugs, or obtain drugs through domestic professional overseas medical service organizations (such as Medical Companion Travel), which are guaranteed to be genuine.

Cycloserine can only be taken orally. The conventional dose is 500mg-1g per day, and the blood drug level is monitored and taken in divided doses. It is not advisable to drink alcohol during application. 1. For adults, take 0.5-1g per day, divided into 2 times. In the first 2 weeks, you can take 0.25g each time, 2 times a day. The maximum dose is 1g per day. 2. For children, take 5 to 20 mg/kg per day, divided into 2 to 4 times, with half the dose for the first dose.

In 2006, a tuberculosis research department in Osaka, Japan, reported that pregnant women using second-line drugs cycloserine, ethambutol, pyrazinamide, etc. were effective in treating multidrug-resistant tuberculosis (MDR-TB), and their newborn babies were healthy. In 2006, a hospital in the Spanish capital used levofloxacin and cycloserine to treat 17 non-HIV-infected multi-drug-resistant tuberculosis patients (68%). After 24 months of follow-up treatment, they were cured without recurrence or death. Iran's Tuberculosis and Infectious Diseases Research Department reported in 2005 that the use of cycloserine in the treatment of MDR-TB can achieve a curative effect.

In addition, the biggest toxic side effect of cycloserine is its impact on the central nervous system, which manifests as emotional agitation and behavioral disorders, as well as convulsions and mental disorders. Taking it together with vitamin B6 can reduce the occurrence of convulsions; peripheral neuritis may occasionally occur, especially when combined with isoniazid.

The above is the content of (cycloserine) medical insurance reimbursement, I hope it can help you!